• Most Popular
  • Most Shared

India's Sun Pharma gets FDA nod for generic Cerebyx

Wed Mar 19, 2008 7:26am EDT

Stocks

   

MUMBAI, March 19 (Reuters) - India's Sun Pharmaceutical Industries Ltd (SUN.BO) said on Wednesday it had received approval from the U.S. Food and Drug Administration for fosphenytoin sodium injection.

Stocks  |  Global Markets

The drug, a generic variant of Pfizer Inc's (PFE.N) Cerebyx, is indicated in the control of certain types of convulsions and for seizures during neurosurgery, Sun said in a statement.

The drug has annual sales of about $15 million, it said. (Reporting by Rina Chandran; Editing by Mark Williams)

Stocks
Global Markets


More from Reuters

Photo

New security restrictions could hurt airlines

NEW YORK (Reuters) - Tighter security measures at U.S. airports following an attempt to blow up a Detroit-bound jet could dampen enthusiasm for air travel, hurting the airline industry just as it seemed poised to recover from a period of bruising losses, some industry experts say.

» More Top News
A Delta Airbus 330 airliner sits on a runway at Detroit Metropolitan Airport in Romulus, Michigan in this video grab made December 25, 2009. Credit: REUTERS/WDIV TV/Handout

The battle in mid-air

The attraction of bombing airliners means the aviation industry has to be constantly vigilant in its fight against attackers.  Full Article 

U.S.
A caution sign is seen next to a stock board at the Australian Securities Exchange (ASX) in Sydney September 5, 2008. REUTERS/Daniel Munoz
Political Risk in 2010:

Don't say we didn't warn you

With the financial crisis (mostly) in the past, U.S. investors are eying a fresh start to the coming year. Here's a look at what speedbumps lie ahead.  Full Article 

Global Markets